NGENLA is a human growth hormone analog indicated for treatment of pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone
We use cookies to ensure that our website works well for you, respecting all rules and good practices for the privacy of your personal data. Agreement page